pI: 5.246 |
Length (AA): 1206 |
MW (Da): 134622 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 7 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
5 | 358 | 4k6j (A) | 721 | 1127 | 11.00 | 0 | 0.04 | 0.309032 | -0.05 |
39 | 265 | 5cwp (A) | 5 | 229 | 14.00 | 0.067 | 0.07 | 0.330226 | -0.77 |
234 | 903 | 4y01 (A) | 51 | 663 | 10.00 | 0 | 0.99 | 0.508056 | 0.97 |
297 | 363 | 2maj (A) | 317 | 387 | 25.00 | 0 | 0.01 | 0.513056 | -3.16 |
298 | 359 | 5hhe (D) | 176 | 237 | 24.00 | 0 | 0.01 | 0.69791 | -4.55 |
298 | 363 | 5hmo (A) | 814 | 887 | 38.00 | 0.00033 | 0.03 | 0.654126 | -3.42 |
1011 | 1186 | 2e5o (A) | 8 | 152 | 33.00 | 0.000000000018 | 0.98 | 0.207937 | 0.74 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | ME49 Tachyzoite, ME49 Oocyst. | Gregory Fritz HM |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 20-40% percentile | VEG Tachyzoite, ME49 merozoite, ME49 Bradyzoite. | Gregory Hehl AB Sibley/Greg |
Hehl AB | Asexual expansion of Toxoplasma gondii merozoites is distinct from tachyzoites and entails expression of non-overlapping gene families to attach, invade, and replicate within feline enterocytes. |
Gregory | ToxoDB |
Fritz HM | Transcriptomic analysis of toxoplasma development reveals many novel functions and structures specific to sporozoites and oocysts. |
Sibley/Greg | ToxoDB |
Ortholog group members (OG5_128655)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT3G47610 | transcription regulator/ zinc ion binding protein |
Babesia bovis | BBOV_III002540 | conserved hypothetical protein |
Brugia malayi | Bm1_42910 | hypothetical protein |
Brugia malayi | Bm1_42915 | Zinc finger motif, C2HC5-type family protein |
Candida albicans | CaO19.9927 | similar to S. cerevisiae YKR023W |
Candida albicans | CaO19.2391 | similar to S. cerevisiae YKR023W |
Caenorhabditis elegans | CELE_Y53F4B.15 | Protein ASC-1 |
Cryptosporidium hominis | Chro.30398 | hypothetical protein |
Cryptosporidium parvum | cgd3_3530 | hypothetical protein |
Dictyostelium discoideum | DDB_G0269884 | hypothetical protein |
Drosophila melanogaster | Dmel_CG11710 | CG11710 gene product from transcript CG11710-RC |
Echinococcus granulosus | EgrG_000142800 | activating signal cointegrator 1 |
Entamoeba histolytica | EHI_104490 | hypothetical protein |
Echinococcus multilocularis | EmuJ_000141800 | activating signal cointegrator 1 |
Echinococcus multilocularis | EmuJ_000142800 | activating signal cointegrator 1 |
Giardia lamblia | GL50803_27694 | Hypothetical protein |
Homo sapiens | ENSG00000103671 | thyroid hormone receptor interactor 4 |
Leishmania braziliensis | LbrM.08.0070 | hypothetical protein, conserved |
Leishmania donovani | LdBPK_080070.1 | Putative zinc finger motif, C2HC5-type/ASCH domain containing protein, putative |
Leishmania infantum | LinJ.08.0070 | hypothetical protein, conserved |
Leishmania major | LmjF.08.0070 | hypothetical protein, conserved |
Leishmania mexicana | LmxM.08.0070 | |
Mus musculus | ENSMUSG00000032386 | thyroid hormone receptor interactor 4 |
Neospora caninum | NCLIV_036650 | putative zinc finger motif, C2HC5-type domain- containing protein |
Oryza sativa | 4347045 | Os09g0413100 |
Saccharomyces cerevisiae | YKR023W | hypothetical protein |
Schistosoma japonicum | Sjp_0308590 | Activating signal cointegrator 1, putative |
Schistosoma japonicum | Sjp_0071860 | Activating signal cointegrator 1, putative |
Schistosoma mansoni | Smp_167590 | hypothetical protein |
Schmidtea mediterranea | mk4.001842.00 | Activating signal cointegrator 1 |
Schmidtea mediterranea | mk4.001842.01 | |
Trypanosoma brucei gambiense | Tbg972.5.5010 | hypothetical protein, conserved |
Trypanosoma brucei | Tb927.5.3590 | Putative zinc finger motif, C2HC5-type/ASCH domain containing protein, putative |
Trypanosoma congolense | TcIL3000_5_4030 | hypothetical protein, conserved |
Trypanosoma congolense | TcIL3000_0_04470 | ASCH domain containing protein, putative |
Trypanosoma cruzi | TcCLB.507811.40 | Putative zinc finger motif, C2HC5-type/ASCH domain containing protein, putative |
Trypanosoma cruzi | TcCLB.511649.160 | Putative zinc finger motif, C2HC5-type/ASCH domain containing protein, putative |
Toxoplasma gondii | TGME49_269940 | zinc finger motif, C2HC5-type protein |
Trichomonas vaginalis | TVAG_056660 | conserved hypothetical protein |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.5.3590 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.5.3590 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.5.3590 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.5.3590 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
TGME49_269940 this record | Toxoplasma gondii | Probably essential | sidik |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.